5.02 USD
▼-0.53-9.55%
盘后 5.07 0.00%
2026-09-15
市值
$113.36M
市盈率
—
EPS
-3.21
股息率
—
52 周区间
3.35 – 17.94
成交量
64.15K
Beta
—
目标价
11.11
52W 低 3.3552W 高 17.94
价格走势
公司简介
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.